speb/financial-data huggingface dataset:
CF.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1439000.00
CF.TO income_statement (annual, 2025-03-31) — Research And Development: 58999000.00
CF.TO income_statement (quarterly, 2025-03-31) — Research And Development: 16850000.00
CF.TO balance_sheet (annual, 2025-03-31) — Restricted Cash: 291824000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 291824000.00
CF.TO income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 8313000.00
CF.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 3669000.00
CF.TO balance_sheet (annual, 2025-03-31) — Retained Earnings: -37604000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -37604000.00
CF.TO income_statement (annual, 2025-03-31) — Selling General And Administration: 270295000.00
CF.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 71646000.00
CF.TO balance_sheet (annual, 2025-03-31) — Share Issued: 102529368.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 102529368.00
CF.TO income_statement (annual, 2025-03-31) — Special Income Charges: -8313000.00
CF.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -3669000.00
CF.TO cash_flow (annual, 2025-03-31) — Stock Based Compensation: 14020000.00
CF.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 11180000.00
CF.TO balance_sheet (annual, 2025-03-31) — Stockholders Equity: 959792000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 959792000.00
CF.TO balance_sheet (annual, 2025-03-31) — Tangible Book Value: -278798000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -278798000.00
CF.TO income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -3088350.00
CF.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 695700.00
CF.TO income_statement (annual, 2025-03-31) — Tax Provision: 28362000.00
CF.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 7416000.00
CF.TO income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.15
CF.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CF.TO balance_sheet (annual, 2025-03-31) — Taxes Receivable: 28095000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 28095000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Assets: 6720547000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 6720547000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Capitalization: 1487727000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1487727000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Debt: 770833000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 770833000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1363715000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1363715000.00
CF.TO income_statement (annual, 2025-03-31) — Total Expenses: 1562970000.00
CF.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 416494000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 5356832000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5356832000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1471294000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1471294000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 946410000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 946410000.00
CF.TO balance_sheet (annual, 2025-03-31) — Total Tax Payable: 7506000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 7506000.00
CF.TO income_statement (annual, 2025-03-31) — Total Unusual Items: -20589000.00
CF.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4638000.00
CF.TO income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -20589000.00
CF.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4638000.00
CF.TO balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 6498541.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 6498541.00
CF.TO cash_flow (annual, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 1500000.00
CF.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 1000000.00
CF.TO balance_sheet (annual, 2025-03-31) — Working Capital: 838831000.00
CF.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 838831000.00
CF.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 107736000.00
CF.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 448447000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2024933000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 851460000.00
CF.TO income_statement (quarterly, 2025-06-30) — Amortization: 12196000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 12196000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 12196000.00
CF.TO income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 12196000.00
CF.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 97245459.00
CF.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.32
CF.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1193201000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1303000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 247382000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 896416000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1261135000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1963032000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -18278000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -33221000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1303000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 107498000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 80119000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -6184000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 521000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 99876000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 73935000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 73935000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -105026000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -6184000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 69306000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -105026000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 72974000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 690775000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -8702000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 683357000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CF.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 295061000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 365105000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 5414496000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 31613000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 702883000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 734496000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4580224000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 31837000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1156000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1156000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 7228000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 19424000.00
CF.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 19424000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 19424000.00
CF.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 19424000.00
CF.TO income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 7228000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 157602000.00
CF.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 97245459.00
CF.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.32
CF.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -30911000.00
CF.TO income_statement (quarterly, 2025-06-30) — EBIT: 21420000.00
CF.TO income_statement (quarterly, 2025-06-30) — EBITDA: 40844000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -5040000.00
CF.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 1261135000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7107000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -33221000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 106195000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 26725000.00
CF.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -26725000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 97877000.00
CF.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 62163000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 676943000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1016738000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 300284000.00
CF.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 153386000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 8040000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 6208000.00
CF.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 33333000.00
CF.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 33333000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 33102000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1917884000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1303000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 7107000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 11263000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 4156000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Leases: 118934000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 215769000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 531644000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 747413000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -11408000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4156000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 409378000.00
CF.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -11214000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income: -28059000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -30911000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -16845000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -28059000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -28059000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -16845000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -16845000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -148000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -33333000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -11408000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -11408000.00
CF.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -33333000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3535000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 300284000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1155000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -127740000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 63367000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 62159000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 84692000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 62159000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 62469000.00
CF.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 65074000.00
CF.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -7463500.00
CF.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 107498000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 26725000.00
CF.TO income_statement (quarterly, 2025-06-30) — Operating Income: 45650000.00
CF.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 441676000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 100006715.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 702883000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 8300000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 97877000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 2806000.00
CF.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 62163000.00
CF.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -24230000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 339795000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 307000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 22223000.00
CF.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6285000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 1409345000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 181350000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2286132000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 701897000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Payables: 3440486000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3805591000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 8433206.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 205641000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -9576000.00
CF.TO income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 2852000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 205641000.00
CF.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -11913000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CF.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CF.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -148000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1155000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 3169107000.00
CF.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 295061000.00
CF.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 19424000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -11408000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CF.TO income_statement (quarterly, 2025-06-30) — Research And Development: 19864000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 282357000.00
CF.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: -2495000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -108101000.00
CF.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 62163000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 102529368.00
CF.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 2495000.00
CF.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 9737000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 888998000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -333381000.00
CF.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3634500.00
CF.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 4932000.00
CF.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
CF.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 31515000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 6868307000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1420642000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 1481909000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1298376000.00
CF.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 402797000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5569931000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1453811000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 989707000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 6208000.00
CF.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -24230000.00
CF.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -24230000.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 2522653.00
CF.TO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
CF.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 834272000.00
CF.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 182566000.00
CF.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 535791000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2264932000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1110238000.00
CF.TO income_statement (quarterly, 2025-09-30) — Amortization: 12467000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 12467000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 12467000.00
CF.TO income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 12467000.00
CF.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 99988000.00
CF.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -2.04
CF.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1261135000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2037000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 255947000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 896711000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1314450000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2069771000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -17993000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -30246000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3280000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 81703000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 492692000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 16976000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -53424000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 154987000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 509668000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 509668000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -518533000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 16976000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 92698000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -518533000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 48177000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 691070000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -8375000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 485220000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CF.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 349622000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 479359000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 6040704000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 29822000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 857870000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 887692000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5230781000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 110018000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 15593000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 15593000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 6340000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 18807000.00
CF.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 18807000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 18807000.00
CF.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 18807000.00
CF.TO income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 6340000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 167885000.00
CF.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 99988000.00
CF.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -2.04
CF.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -203564000.00
CF.TO income_statement (quarterly, 2025-09-30) — EBIT: -124107000.00
CF.TO income_statement (quarterly, 2025-09-30) — EBITDA: -105300000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 5138000.00
CF.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 1314450000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7281000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -30246000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 79666000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 10472000.00
CF.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -10472000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 113430000.00
CF.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 137983000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 572671000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 905094000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 296804000.00
CF.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 186169000.00
CF.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 110000000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 7660000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 8412000.00
CF.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 34433000.00
CF.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 34433000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 34205000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1877112000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3280000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 7281000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 11113000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 3832000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Leases: 117121000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 226125000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 534022000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 760147000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -12253000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3832000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 416798000.00
CF.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -13902000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 77442000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income: -200712000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -203564000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -186810000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -200712000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -200712000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -186810000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -186810000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -172000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -34433000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -12253000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -12253000.00
CF.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -34433000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 296804000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1865000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -214233000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 56497000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 46207000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 89947000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 46207000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 61253000.00
CF.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 22410000.00
CF.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -92158500.00
CF.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 81703000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 10472000.00
CF.TO income_statement (quarterly, 2025-09-30) — Operating Income: 3603000.00
CF.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 524164000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 99823269.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 857870000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6982000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 113430000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2806000.00
CF.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 137983000.00
CF.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -127710000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 332423000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 11359000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 28694000.00
CF.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 5686000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 1473386000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 179683000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2486757000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 755321000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Payables: 3746730000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4226089000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 8433206.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 205641000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -9618000.00
CF.TO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 2852000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 205641000.00
CF.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -158540000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CF.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CF.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -172000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1865000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 3618830000.00
CF.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 349622000.00
CF.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 18807000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -12253000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CF.TO income_statement (quarterly, 2025-09-30) — Research And Development: 20090000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 352103000.00
CF.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 7238000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -322086000.00
CF.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 137983000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 102529368.00
CF.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -117238000.00
CF.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 9584000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 690861000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -419874000.00
CF.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -19156500.00
CF.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 28270000.00
CF.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CF.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 21835000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 7356419000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1224883000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 1647839000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1107659000.00
CF.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 532188000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6248760000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1315715000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1017979000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 8412000.00
CF.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -127710000.00
CF.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -127710000.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 2706099.00
CF.TO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
CF.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 809923000.00
CF.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 120132000.00
CF.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 637861000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2126736000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 841400000.00
CF.TO income_statement (quarterly, 2025-12-31) — Amortization: 13667000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 13667000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 13667000.00
CF.TO income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 13667000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CF.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 100192815.00
CF.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.19
CF.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1314450000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1719000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 255533000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 900710000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1670860000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2297755000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -18336000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5656000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15531000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 371694000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 128426000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -287460000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -550369000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1003565000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 294162000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 983710000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 361819000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 695069000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -8593000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 488710000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -2297000.00
CF.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 407199000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 617541000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 5291248000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 30459000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 577729000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 608188000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4444360000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 108563000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 5563000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 5563000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 7379000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 21046000.00
CF.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 21046000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 21046000.00
CF.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 21046000.00
CF.TO income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 7379000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 178413000.00
CF.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 104376388.00
CF.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.18
CF.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 18936000.00
CF.TO income_statement (quarterly, 2025-12-31) — EBIT: 94990000.00
CF.TO income_statement (quarterly, 2025-12-31) — EBITDA: 116036000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -5409000.00
CF.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 1670860000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5656000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 369975000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 12176000.00
CF.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -12176000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 107269000.00
CF.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 69540000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 577038000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 922081000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 296710000.00
CF.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 230662000.00
CF.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CF.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 12046000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 16425000.00
CF.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 30773000.00
CF.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 30773000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 30415000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1626855000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -15531000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 11348000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Leases: 117337000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 225074000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 560416000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 785490000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -12137000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 420987000.00
CF.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -16835000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -30265000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2297000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income: 21788000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 18936000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 38623000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 21788000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 21788000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 38623000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 38623000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -116000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -30773000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 26289000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 26289000.00
CF.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -30773000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 16453000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 296710000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1603000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -227730000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 56408000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 35879000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 90073000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 35879000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 60307000.00
CF.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 131576000.00
CF.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 31134456.86
CF.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 371694000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -7706000.00
CF.TO income_statement (quarterly, 2025-12-31) — Operating Income: 110530000.00
CF.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 607370000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 100416797.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 577729000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 6070000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 107269000.00
CF.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 69540000.00
CF.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -15540000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 345043000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8175000.00
CF.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6279000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 960837000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 179373000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1726845000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 626895000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Payables: 3103998000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3721539000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 8433206.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 205641000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -9743000.00
CF.TO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2852000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 205641000.00
CF.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 64217000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CF.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -30265000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -116000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1603000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 2583043000.00
CF.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 407199000.00
CF.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 21046000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -12137000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2297000.00
CF.TO income_statement (quarterly, 2025-12-31) — Research And Development: 23267000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 410450000.00
CF.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 3364000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -313628000.00
CF.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 69540000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 102734159.00
CF.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -3364000.00
CF.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 11831000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 694351000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -433371000.00
CF.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -6193543.14
CF.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 25594000.00
CF.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.40
CF.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 14798000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 6613674000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1254767000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1393678000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1115338000.00
CF.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 527331000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5498336000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1322426000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1053976000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 16425000.00
CF.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -15540000.00
CF.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -15540000.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2317362.00
CF.TO cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CF.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 846888000.00
CF.TO income_statement (annual, 2026-03-31) — +Operating Expense: 524703000.00